FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Comments Extended on Abuse-deterrent Properties for Opioids

Federal Register Notice: FDA extends the comment period related to its public meeting on Pre-Market Evaluation of Abuse-Deterrent Properties of Opioid...

Medical Devices

FDA Clears Kyocera Medical Total Hip System

Kyocera Medical Corp. receives 510(k) clearance for its Initia Total Hip System which features Bioceram Azul (blue) zirconia-toughened alumina ceramic...

Biologics

Kite Pharma Begins BLA for CAR-T Cell Therapy

Kite Pharma begins a rolling BLA submission for KTE-C19 (axicabtagene ciloleucel) as a treatment for patients with relapsed/refractory aggressive B-ce...

Medical Devices

FDA Posts Transcript of Device User Fee Program Meeting

FDA posts a transcript of its 11/2 public meeting on Medical Device User Fee Amendments that discussed proposed recommendations for reauthorizing the ...

Federal Register

Guidance on Clin Pharm Labeling for Drugs

Federal Register Notice: FDA makes available a guidance entitled Clinical Pharmacology Section of Labeling for Human Prescription Drug and Biological ...

Federal Register

Comments on Device GMPs and Quality System Regulations

Federal Register Notice: FDA seeks comments on an information collection extension request related to Medical Device: Current Good Manufacturing Pract...

Federal Register

Comments Sought on Symbols on IVD Labels

Federal Register Notice: FDA seeks comments on an OMB submission to extend an information collection related to a recommended glossary and educational...

Human Drugs

CDER New Drugs Director Jenkins to Retire

After almost 25 years at FDA, CDER Office on New Drugs director John Jenkins announces his retirement.

Human Drugs

Comments Sought on Device Pediatric Use Information

Federal Register Notice: FDA seeks comments on an information collection extension request related to a guidance on Providing Information About Pediat...

Federal Register

Guidance on Clin Pharm Labeling for Drugs

Federal Register Notice: FDA makes available a guidance entitled Clinical Pharmacology Section of Labeling for Human Prescription Drug and Biological ...